These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7583341)

  • 21. Activation of 5-HT
    Tavares LRR; Baptista-de-Souza D; Canto-de-Souza A
    Neuropharmacology; 2018 Jun; 135():376-385. PubMed ID: 29548885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tricyclic antidepressants, but not the selective serotonin reuptake inhibitor fluoxetine, bind to the S1S2 domain of AMPA receptors.
    Stoll L; Seguin S; Gentile L
    Arch Biochem Biophys; 2007 Feb; 458(2):213-9. PubMed ID: 17214956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of 5-HT
    Colmenares-Aguilar M; Lima L
    Adv Exp Med Biol; 2017; 975 Pt 2():1129-1140. PubMed ID: 28849528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
    Laakso A; Pälvimäki EP; Kuoppamäki M; Syvälahti E; Hietala J
    Neuropsychopharmacology; 1996 Aug; 15(2):143-51. PubMed ID: 8840350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides.
    Jørgensen H; Kjaer A; Knigge U; Møller M; Warberg J
    J Neuroendocrinol; 2003 Jun; 15(6):564-71. PubMed ID: 12716407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression.
    Tilakaratne N; Yang Z; Friedman E
    Eur J Pharmacol; 1995 Aug; 290(3):263-6. PubMed ID: 7589222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
    Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TREK-1 isoforms generated by alternative translation initiation display different susceptibility to the antidepressant fluoxetine.
    Eckert M; Egenberger B; Döring F; Wischmeyer E
    Neuropharmacology; 2011; 61(5-6):918-23. PubMed ID: 21740918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation.
    Li B; Zhang S; Li M; Hertz L; Peng L
    Psychopharmacology (Berl); 2009 Nov; 207(1):1-12. PubMed ID: 19662385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral and spinal 5-HT receptors participate in the pronociceptive and antinociceptive effects of fluoxetine in rats.
    Cervantes-Durán C; Rocha-González HI; Granados-Soto V
    Neuroscience; 2013 Nov; 252():396-409. PubMed ID: 23994595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.
    Goodnick PJ; Goldstein BJ
    J Psychopharmacol; 1998; 12(3 Suppl B):S5-20. PubMed ID: 9808077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.
    Herges S; Taylor DA
    Pharmacol Biochem Behav; 1998 Mar; 59(3):595-611. PubMed ID: 9512061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulus properties of fluvoxamine in a conditioned taste aversion procedure.
    Gommans J; Bouwknecht JA; Hijzen TH; Berendsen HH; Broekkamp CL; Maes RA; Olivier B
    Psychopharmacology (Berl); 1998 Dec; 140(4):496-502. PubMed ID: 9888626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.